Degranulation Assay

Receptor recognition initiates intracellular signaling that raises calcium concentrations inside the immune cell. This calcium signal promotes fusion of secretory granules with the plasma membrane, allowing their contents to be released. Measuring the resulting surface-marker exposure or mediator release connects receptor stimulation to a functional cellular response rather than simply detecting receptor presence.

CD107a becomes exposed at the cell surface when intracellular granules fuse with the plasma membrane, making it a marker of the degranulation event. Its detection provides a way to quantify activation by flow cytometry or microscopy, while measurements of released granzymes, perforin, or histamine provide complementary information about the mediators associated with that response.

The relevant readout depends on the leukocyte being studied. Natural killer cells and cytotoxic T cells can be evaluated through granule-associated cytotoxic mediators such as granzymes and perforin, whereas mast-cell responses can be examined through histamine release. This cell-type context helps researchers interpret whether a stimulus produces cytotoxic or other mediator-focused activity.

Flow cytometry can quantify marker exposure on responding cells, while microscopy provides a visual approach for examining cellular or membrane-associated changes. Mediator-specific measurements instead assess released products such as granzymes, perforin, or histamine. Selecting among these approaches depends on whether the experiment emphasizes responding-cell frequency, visible events, or the type of released mediator.

A typical assessment begins by exposing the relevant immune cells to a target or stimulus that engages their receptors. The response is then evaluated for granule-associated surface markers, visible changes, or released mediators using flow cytometry, microscopy, or mediator-specific measurements. The resulting signal indicates how strongly the cells responded functionally to that stimulus.

In infection research, the assay can reveal whether pathogen-associated stimulation activates immune cells and elicits a functional response. Investigators may examine natural killer cells, cytotoxic T cells, or other leukocytes and quantify marker exposure or mediator release. These results help connect immune-cell activation with the capacity to respond during pathogen exposure.

The readout can be used to evaluate cytotoxic function, investigate immune deficiencies, and assess responses to vaccines or therapies. Because it measures a functional consequence of receptor stimulation, the assay can distinguish cellular activity from simple immune-cell presence. Comparing marker or mediator signals across conditions helps characterize differences in immune performance or treatment response.